☆ 4.8 Letter

Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species

GUT (2020)

期刊

GUT

卷 69, 期 10, 页码 1890-1892

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/gutjnl-2019-320008

关键词

primary sclerosing cholangitis; mycobiome

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Gastroenterology & Hepatology

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

Qiaoyan Liu, Bo Li, Yikang Li, Yiran Wei, Bingyuan Huang, Jubo Liang, Zhengrui You, You Li, Qiwei Qian, Rui Wang, Jun Zhang, Ruiling Chen, Zhuwan Lyu, Yong Chen, Mingxia Shi, Xiao Xiao, Qixia Wang, Qi Miao, Jing-Yuan Fang, Merrill Eric Gershwin, Min Lian, Xiong Ma, Ruqi Tang

Summary: Comparative analysis of gut microbiome and metabolome in IgG4-SC and PSC patients revealed distinct host-microbe interactions that may contribute to disease pathogenesis, highlighting the uniqueness of IgG4-SC.

GUT (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics

Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim

Summary: Cholangiopathies are various biliary diseases that affect the biliary epithelium and can lead to cholestasis and liver cirrhosis. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the most important progressive cholangiopathies in adults, with research focusing on genetic risk, epigenetic changes, dysregulated mucosal immunity, and altered biliary epithelial cell function. Understanding the molecular pathogenesis of these diseases can help clinicians prevent and treat them more effectively.

BIOMEDICINES (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis

Daniel E. Radford-Smith, Emmanuel A. Selvaraj, Rory Peters, Michael Orrell, Jonathan Bolon, Daniel C. Anthony, Michael Pavlides, Kate Lynch, Alessandra Geremia, Adam Bailey, Emma L. Culver, Fay Probert

Summary: Serum metabolomic profiling has the potential to accurately distinguish between PSC and IgG4-SC, improve the diagnosis of IgG4-RD, and differentiate IgG4-SC from PSC.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Treatment of primary sclerosing cholangitis

Annarosa Floreani, Sara De Martin

Summary: PSC is a chronic cholestatic liver disease with no effective treatment currently available. There is controversy over the use of UDCA in PSC treatment. Novel pharmacological strategies targeting bile composition, immunomodulation, gut microbiome, and fibrosis are emerging, suggesting potential for personalized combination therapies for successful PSC treatment.

DIGESTIVE AND LIVER DISEASE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Microbial manipulation as therapy for primary sclerosing cholangitis

Damjana Bogatic, Robert Bryant, Kate D. Lynch, Samuel P. Costello

Summary: Primary sclerosing cholangitis (PSC) is a progressive liver disease with poor prognosis and no effective therapies to prevent progression. This study evaluated potential medical therapies that may exert their effects in PSC by modulation of the gut-liver axis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Current Therapeutics in Primary Sclerosing Cholangitis

Natassia Tan, John Lubel, William Kemp, Stuart Roberts, Ammar Majeed

Summary: Primary sclerosing cholangitis (PSC) is an orphan, cholestatic liver disease characterized by inflammatory biliary strictures. The pathophysiology of PSC is poorly understood, but it is likely driven by immune dysregulation, gut dysbiosis, and environmental exposures. Currently, there is no proven medical therapy to alter disease progression in PSC, and liver transplantation is the only option for end-stage liver disease. Manipulation of the gut microbiome and bile acid metabolism show promise in phase II trials. Statins and aspirin may reduce the risk of malignancy in PSC patients. Balloon dilatation is safer and equally effective compared to biliary stent insertion for clinically relevant strictures.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence

Fuat H. Saner, Alexandra Frey, Bjoern-Ole Stueben, Dieter P. Hoyer, Katharina Willuweit, Martina Daniel, Jassin Rashidi-Alavieh, Jurgen W. Treckmann, Hartmut H. Schmidt

Summary: In this retrospective study of 82 patients who underwent liver transplantation for primary sclerosing cholangitis (PSC), the authors assessed morbidity, survival rates, PSC recurrence, and the impact of donor characteristics in long-term follow-up. The study showed that PSC patients had excellent 10-year survival rates and a lower lab-MELD score was associated with longer survival. Donor characteristics did not affect patient survival.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis

Daniel R. Ludwig, Mark A. Anderson, Malak Itani, Kedar G. Sharbidre, Neeraj Lalwani, Raj M. Paspulati

Summary: This article reviews the clinical features, pathogenesis, diagnosis, and imaging findings of primary and secondary sclerosing cholangitis. It also discusses various etiologies of secondary sclerosing cholangitis, highlighting the unique imaging findings and clinical context of each diagnosis.

ABDOMINAL RADIOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Patient-reported quality of care in primary sclerosing cholangitis

Martine Walmsley, David Tornai, Nora Cazzagon, Angela Leburgue, Anna Mrzljak, Henrike Lenzen, Marco Carbone, Joao Madaleno, Ana Lleo, Norman Junge, Christoph Schramm, Annika Bergquist

Summary: The aim of this study was to assess patient-reported quality of care in primary sclerosing cholangitis (PSC) and identify areas for improvement. The results indicated that PSC patients experience a high symptom burden and would benefit from more widespread use of elastography, bone density scan, and appropriate treatment for itch. Personalized prognostic information and guidance on improving health should be provided to individuals with PSC.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Recent Advances in the Management of Primary Sclerosing Cholangitis

David N. Assis, Christopher L. Bowlus

Summary: Primary sclerosing cholangitis (PSC) is a chronic liver disease characterized by fibroinflammatory damage to the biliary tree. It is often associated with inflammatory bowel disease and carries an increased risk of liver failure and cholangiocarcinoma. The complexity of the disease and lack of effective therapy have been challenges, but recent advancements in patient characterization, prognostication, and medical management offer hope for progress in the future. This review summarizes current understanding of PSC and highlights areas for further investigation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Primary Sclerosing Cholangitis-Associated Pouchitis: A Distinct Clinical Phenotype

Kevin P. Quinn, Siri A. Urquhart, Laurens P. Janssens, Ryan J. Lennon, Victor G. Chedid, Laura E. Raffals

Summary: Patients with primary sclerosing cholangitis (PSC) who undergo ileal pouch-anal anastomosis (IPAA) are more likely to develop pouchitis compared to non-PSC patients. PSC-associated pouchitis presents with unique clinical characteristics, including chronic pouchitis, moderate-to-severe pouch inflammation, prepouch ileitis, and less response to conventional antimicrobial therapy.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group

Sudhakar K. Venkatesh, Christopher L. Welle, Frank H. Miller, Kartik Jhaveri, Kristina Ringe, John E. Eaton, Helen Bungay, Lionel Arrive, Ahmed Ba-Ssalamah, Aristeidis Grigoriadis, Christoph Schramm, Ann S. Fulcher

Summary: Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder that affects the bile ducts and increases the risk of hepato-biliary malignancies. MRI/MRCP is considered the imaging standard, but there are no universally accepted reporting standards or definitions.

EUROPEAN RADIOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis

Raanan Greenman, Michal Segal-Salto, Neta Barashi, Ophir Hay, Avi Katav, Omer Levi, Ilan Vaknin, Revital Aricha, Sarit Aharoni, Tom Snir, Inbal Mishalian, Devorah Olam, Johnny Amer, Ahmad Salhab, Rifaat Safadi, Yaakov Maor, Palak Trivedi, Christopher J. Weston, Francesca Saffioti, Andrew Hall, Massimo Pinzani, Douglas Thorburn, Amnon Peled, Adi Mor

Summary: CCL24 is involved in fibrosis and inflammation in liver and its inhibition can reduce liver injury. This study found that blocking CCL24 improves inflammation, fibrosis, and cholestasis in PSC, and reduces proliferation and senescence of cholangiocytes.

JCI INSIGHT (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Serological biomarkers for management of primary sclerosing cholangitis

David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos, Maria Papp

Summary: The clinical manifestations and progression of primary sclerosing cholangitis (PSC) vary, and its pathogenesis is not well understood. Gut-liver interactions play an important role in the development of PSC. Recent advances in biomarkers research may help identify clinically relevant PSC subgroups and assist in diagnosis, disease stratification, and potential therapeutic targets.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis

Martin Kummen, Louise B. Thingholm, Malte C. Ruhlemann, Kristian Holm, Simen H. Hansen, Lucas Moitinho-Silva, Timur Liwinski, Roman Zenouzi, Christopher Storm-Larsen, Oyvind Midttun, Adrian McCann, Per M. Ueland, Marte L. Hoivik, Mette Vesterhus, Marius Troseid, Matthias Laudes, Wolfgang Lieb, Tom H. Karlsen, Corinna Bang, Christoph Schramm, Andre Franke, Johannes R. Hov

Summary: The study found significant functional differences in the gut microbiome of PSC patients, including microbial metabolism of essential nutrients. Changes in related circulating metabolites associated with disease course suggest that microbial functions may be relevant for the disease process in PSC.

GASTROENTEROLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC

Muyiwa Awoniyi, Jeremy Wang, Billy Ngo, Vik Meadows, Jason Tam, Amba Viswanathan, Yunjia Lai, Stephanie Montgomery, Morgan Farmer, Martin Kummen, Louise Thingholm, Christoph Schramm, Corinna Bang, Andre Franke, Kun Lu, Huiping Zhou, Jasmohan S. Bajaj, Phillip B. Hylemon, Jenny Ting, Yury Popov, Johannes Roksund Hov, Heather L. Francis, Ryan Balfour Sartor

Summary: By studying the microbial composition in germ-free and antibiotic-treated mice and PSC patients, we identified different bacterial species with functional protective and detrimental effects in these animals and patients, which are associated with clinical risk scores. These findings are important for the development of personalized therapeutic approaches.

GUT (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Mikal Jacob Hole, Kristin Kaasen Jorgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer-Myklestad, Asle Wilhelm Medhus, Dag Henrik Reikvam, Alexandra Gotz, Krzysztof Grzyb, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov

Summary: This study investigated the characteristics of the gut microbiota in patients with primary sclerosing cholangitis (PSC) and found several features associated with PSC, including an expansion of Proteobacteria and increased variability. Furthermore, certain genera and the presence of the pathobiont Klebsiella were associated with reduced survival in PSC patients, and concomitant inflammatory bowel disease (IBD) was associated with reduced levels of Akkermansia.

HEPATOLOGY (2023)

添加到收藏夹

Article Allergy

Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses

Mari Kaarbo, Mingyi Yang, Johannes R. Hov, Kristian Holm, Mirta Mittelstedt Leal de Sousa, Magnhild E. Macpherson, Henrik M. Reims, Anne-Marte Bakken Kran, Bente Halvorsen, Tom H. Karlsen, Pal Aukrust, Knut E. A. Lundin, Borre Fevang, Magner Bjoras, Silje Fjellgard Jorgensen

Summary: This study aimed to investigate the role of the duodenal microenvironment in the pathogenesis of duodenal inflammation in CVID. The findings suggest altered functions of the duodenal epithelium, particularly in response to lipopolysaccharide and viruses. Viruses, rather than gluten sensitivity, could be related to duodenal inflammation in CVID.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?

Ayodeji Awoyemi, Johannes R. Hov, Marius Troseid

CIRCULATION-HEART FAILURE (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis

Juliane Glaubitz, Anika Wilden, Fabian Frost, Sabine Ameling, Georg Homuth, Hala Mazloum, Malte Christoph Ruehlemann, Corinna Bang, Ali A. Aghdassi, Christoph Budde, Tilmann Pickartz, Andre Franke, Barbara M. Broeker, Uwe Voelker, Julia Mayerle, Markus M. Lerch, Frank-Ulrich Weiss, Matthias Sendler

Summary: Understanding the role of T-reg/Th17 balance in maintaining intestinal barrier function is important for reducing the risk of severe disease and late death in acute pancreatitis (AP). Depletion of T-reg cells enhances the proinflammatory response and reduces bacterial translocation to the pancreas in a mouse model of AP. Targeting T-regs may help improve the course of the disease.

GUT (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Microbial Dynamics in Newly Diagnosed and Treatment Naive IBD Patients in the Mediterranean

Philipp Rausch, Sarah Ellul, Anthea Pisani, Corinna Bang, Trevor Tabone, Claire Marantidis Cordina, Graziella Zahra, Andre Franke, Pierre Ellul

Summary: Background: Microbial communities are believed to influence inflammatory processes in patients with inflammatory bowel disease (IBD), but these effects are often influenced by treatments and rarely studied in treatment-naive patients. Methods: Untreated IBD onset patients and healthy controls were recruited from Malta. Stool samples were collected and analyzed via sequencing to assess microbial communities. Results: Differences in community composition, variability, and diversity were observed between healthy and diseased individuals, but minimal differences were found between newly diagnosed UC and CD cohorts. Network analyses revealed changes in bacterial interactions, suggesting disease-specific alterations in community dynamics. Additionally, microbial community characteristics were identified as predictors for future treatments. Conclusion: Treatment-naive IBD onset patients from Malta show differences in microbial communities compared to healthy individuals, and future treatment options can be predicted based on microbial community characteristics.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Article Oncology

Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

Stefanie V. V. Junk, Elke Schaeffeler, Martin Zimmermann, Anja Moericke, Rita Beier, Peter Schuette, Birthe Fedders, Julia Alten, Laura Hinze, Norman Klein, Andreas Kulozik, Martina U. U. Muckenthaler, Rolf Koehler, Arndt Borkhardt, Jayaram Vijayakrishnan, David Ellinghaus, Michael Forster, Andre Franke, Astrid Wintering, Christian P. P. Kratz, Martin Schrappe, Matthias Schwab, Richard S. S. Houlston, Gunnar Cario, Martin Stanulla

Summary: This study analyzed the impact of therapy-related hyperbilirubinemia on the treatment outcome of pediatric patients with acute lymphoblastic leukemia (ALL) and identified the contributing genetic risk factors. The study found that high hyperbilirubinemia had a negative impact on treatment outcome, and the rs6744284 variant in the UGT1A gene cluster was strongly associated with the risk of hyperbilirubinemia.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

添加到收藏夹

Article Biochemical Research Methods

Pathogen detection in RNA-seq data with Pathonoia

Anna-Maria Liebhoff, Kevin Menden, Alena Laschtowitz, Andre Franke, Christoph Schramm, Stefan Bonn

Summary: Pathonoia is an algorithm that detects viruses and bacteria in RNA sequencing data with high precision and recall, and provides an easy-to-use analysis framework to highlight potential microbe-host interactions.

BMC BIOINFORMATICS (2023)

添加到收藏夹

Article Microbiology

Fast Identification Method for Screening Bacteria from Faecal Samples Using Oxford Nanopore Technologies MinION Sequencing

Ana Sofia G. Borges, Meghna Basu, Erik Brinks, Corinna Bang, Gyu-Sung Cho, John F. F. Baines, Andre Franke, Charles M. A. P. Franz

Summary: This study develops a fast and robust method for identifying lactobacilli, bifidobacteria, and Bacteroides in human fecal samples. The method involves selective culturing, sonication-based DNA extraction, 16S rRNA gene PCR amplification, and MinION sequencing. The method provides quick and accurate identification of bacteria and is advantageous for screening target microorganisms in culturomics studies.

CURRENT MICROBIOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Physical activity-induced alterations of the gut microbiota are BMI dependent

Shrushti Shah, Chunlong Mu, Shirin Moossavi, Grace Shen-Tu, Kristina Schlicht, Nathalie Rohmann, Corinna Geisler, Matthias Laudes, Andre Franke, Thomas Zuellig, Harald Koefeler, Jane Shearer

Summary: Physical inactivity is a leading cause of chronic metabolic diseases, including obesity. Increasing physical activity has been shown to have positive effects on cardiometabolic and musculoskeletal health in athletes. However, the impact of physical activity on the gut microbiota in individuals who engage in regular physical activity in their daily lives is unclear.

FASEB JOURNAL (2023)

添加到收藏夹

Letter Gastroenterology & Hepatology

Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients

Andreea Zamfir-Taranu, Britt-Sabina Loescher, Diab M. Husein, Abdullah Hoter, Koldo Garcia-Etxebarria, Usune Etxeberria, Lucia Gayoso, Gabriele Mayr, Clara Nilholm, Rita J. Gustafsson, Oliver Ozaydin, Tenghao Zheng, Cristina Esteban-Blanco, Isotta Bozzarelli, Ferdinando Bonfiglio, Sandra Rizk, Andre Franke, Luis Bujanda, Hassan Y. Naim, Bodil Ohlsson, Mauro D'Amato

GUT (2023)

添加到收藏夹

Article Allergy

Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma

Jelle M. Blankestijn, Alejandro Lopez-Rincon, Anne H. Neerincx, Susanne J. H. Vijverberg, Simone Hashimoto, Mario Gorenjak, Olaia Sardon Prado, Paula Corcuera-Elosegui, Javier Korta-Murua, Maria Pino-Yanes, Uros Potocnik, Corinna Bang, Andre Franke, Christine Wolff, Susanne Brandstetter, Antoaneta A. Toncheva, Parastoo Kheiroddin, Susanne Harner, Michael Kabesch, Aletta D. Kraneveld, Mahmoud Abdel-Aziz, Anke H. Maitland-van der Zee

Summary: This study aimed to investigate whether the gastrointestinal microbiome can differentiate between uncontrolled and controlled asthma in children. By analyzing samples from 143 children with moderate-to-severe asthma, it was found that machine learning, specifically REFS, can differentiate the control level of asthma in children. The results suggest that the gastrointestinal microbiome may be a potential biomarker for treatment responsiveness and help improve asthma control in children.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis

Younghun Y. Han, Jinyoung J. Byun, Catherine Zhu, Ryan R. Sun, Julia Y. Roh, Heather Cordell, Hyun-Sung A. Lee, Vikram R. Shaw, Sung Wook Kang, Javad Razjouyan, Matthew A. Cooley, Manal M. Hassan, Katherine A. Siminovitch, Trine Folseraas, David Ellinghaus, Annika Bergquist, Simon M. Rushbrook, Andre Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Katherine A. McGlynn, Lewis R. Roberts, Christopher Amos, Christoph Schramm, David Shapiro, Elizabeth Goode

Summary: This study used multitrait joint analyses to explore the genetic contribution and correlations between various clinical and epidemiological traits associated with PSC. Several new risk loci and potential susceptibility genes such as MANBA and IRF5 were identified, and in silico drug screening provided candidate agents for further investigation of pharmacological effects in PSC.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Biology

Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection

Flora Mikaeloff, Marco Gelpi, Rui Benfeitas, Andreas D. Knudsen, Beate Vestad, Julie Hogh, Johannes R. Hov, Thomas Benfield, Daniel Murray, Christian G. Giske, Adil Mardinoglu, Marius Troseid, Susanne D. Nielsen, Ujjwal Neogi, Niel Hens

Summary: Multiomics technologies were used to stratify and characterize the metabolic risk profile in people living with HIV (PWH) on antiretroviral therapy. Through network analysis and similarity network fusion (SNF), three groups of PWH were identified: healthy-like, mild at-risk, and severe at-risk. PWH in the severe at-risk group had a high incidence of metabolic syndrome and dysregulated metabolic traits, despite having higher CD4(+) T-cell counts. The microbiome profile differed between the healthy-like group and the at-risk groups, potentially contributing to systemic inflammation and cardiometabolic risk.

ELIFE (2023)

添加到收藏夹

Article Critical Care Medicine

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19

Marius Troseid, Jan Cato Holter, Kristian Holm, Beate Vestad, Taisiia Sazonova, Beathe K. Granerud, Anne Ma Dyrhol-Riise, Aleksander R. Holten, Kristian Tonby, Anders Benjamin Kildal, Lars Heggelund, Anders Tveita, Simen Boe, Karl Erik Muller, Synne Jenum, Johannes R. Hov, Thor Ueland

Summary: The gut microbiota of hospitalized COVID-19 patients is altered, with reduced diversity and a different composition in those requiring intensive care unit (ICU) admission. This altered gut microbiota is associated with ICU admission and 60-day mortality. These findings suggest that gut microbiota alterations during hospitalization may be related to poor prognosis in severe COVID-19.

CRITICAL CARE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.